Variability in aspirin efficacy: all in the genes?

This editorial refers to ‘Genetic variation at the coronary artery disease locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin’, by K.T. Hall et al., doi:10.1093/eurheartj/ehz384.

Bibliographic Details
Main Authors:	Baigent, C, Holmes, M
Format:	Journal article
Published:	Oxford University Press 2019

Similar Items

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
by: Collins, R, et al.
Published: (1996)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
by: Patrono, C, et al.
Published: (2010)

Aspirin for everyone older than 50? Against.
by: Baigent, C
Published: (2005)

Aspirin for disease prevention: public policy or personal choice?
by: Baigent, C
Published: (2016)

Role of aspirin in primary prevention of cardiovascular disease
by: Patrono, C, et al.
Published: (2019)

Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
by: Wong, C, et al.
Published: (2014)

Low-dose aspirin for the prevention of atherothrombosis.
by: Patrono, C, et al.
Published: (2005)

Immediate aspirin for suspected ischaemic stroke.
by: Baigent, C, et al.
Published: (1999)

Prevention. Aspirin in primary prevention--good news and bad news.
by: Hennekens, C, et al.
Published: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
by: Hennekens, C, et al.
Published: (2012)

Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
by: Baigent, C, et al.
Published: (2001)

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
by: Baigent, C, et al.
Published: (2003)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
by: Patrono, C, et al.
Published: (2005)

Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.
by: Patrono, C, et al.
Published: (2009)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
by: Hennekens, C, et al.
Published: (2006)

Efficacy and safety of simvastatin and safety of low-dose aspirin among patients with chronic kidney disease: Final results of the first UK-Heart and Renal Protection (UK-HARP-1) study.
by: Baigent, C, et al.
Published: (2002)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
by: Collins, R, et al.
Published: (1997)

Aspirin and stroke.
by: Buring, J, et al.
Published: (1990)

The adverse effects of different doses of aspirin: a systematic overview of randomised trials and observational studies
by: Sudlow, G, et al.
Published: (2000)

Aspirin and the stomach.
by: Langston, H
Published: (1981)

All systems GO for understanding mouse gene function
by: Holmes, C, et al.
Published: (2004)

Aspirin, salicylates and cancer
by: Morgan, G, et al.
Published: (2011)

ASPIRIN AND THE STOMACH - REPLY
by: Doll, R, et al.
Published: (1981)

Aspirin and transient ischaemic attacks.
by: Peto, R, et al.
Published: (1979)

Aspirin in ischemic heart disease.
by: Hennekens, C, et al.
Published: (1992)

ASPIRIN USE AND CHRONIC DISEASES
by: Hennekens, C, et al.
Published: (1990)

Effects of aspirin for primary prevention in persons with diabetes mellitus
by: Bowman, L, et al.
Published: (2018)

Aspirin in the prevention of cancer Reply
by: Rothwell, P
Published: (2011)

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
by: Baigent, C, et al.
Published: (2005)

Low-dose aspirin for migraine prophylaxis.
by: Buring, J, et al.
Published: (1990)

An overview of the British and American aspirin studies.
by: Hennekens, C, et al.
Published: (1988)

Aspirin in patients undergoing noncardiac surgery.
by: Devereaux, P, et al.
Published: (2014)

The efficacy and safety of aspirin in individuals with and without diabetes: A collaborative meta-analysis of individual participant data from randomised trials
by: Wong, C
Published: (2014)

Aspirin in the chemoprevention of colorectal neoplasia: an overview.
by: Chan, A, et al.
Published: (2012)

Using anticoagulation or aspirin to prevent stroke. Study does not have the power to show that aspirin is as good as anticoagulation.
by: Mant, J, et al.
Published: (2000)

Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
by: Antoniades, C, et al.
Published: (2007)

Aspirin for prevention of cancer and cardiovascular disease.
by: Rose, P, et al.
Published: (2011)

Aspirin for everyone older than 50? For.
by: Elwood, P, et al.
Published: (2005)